CUA Educational Content

Unraveling the Power of Precision Medicine with PARP Inhibitors

Recording from June 22, 2023

Speakers: Noel Clarke, Maria Jiang, Aly-Khan Lalani, Krista Noonan 


  • understand the importance of genetic testing for their patients with advanced prostate cancer
  • advocate for efficacy and safety data from randomized control trials investigating PARPi in mCRPC
  • engage real-world case-based discussion surrounding PARPi use in patients with mCRPC


This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1 hour of credit.


This program has received financial support from Astra Zeneca / Merck in the form of an educational grant.